Patent granted for Lyme test technology:
This article was originally published in Clinica
Executive Summary
The Mayo Foundation has gained a US patent covering the technology used in Imugen's Lyme infection test, which the Norwood, Massachusetts-based company licenses from the Foundation. The test is able to identify Lyme infection even in people who have recently received the Lyme vaccine - this is important because people in endemic areas may be at risk of contracting Lyme disease while undergoing vaccine regimens (the vaccine is maximally effective after three doses).